The landscape of today’s clinical trials is ever changing, posing greater challenges for sponsors, investigators and FDA alike. Challenges include increased complexity, novel therapies, large multi-site trials, inclusion of vulnerable patients, trials conducted outside of the United States, and outsourcing of various trial related responsibilities. In response to these complexities, FDA is implementing several new initiatives to maintain better oversight, and sponsors and investigators will need to be more vigilant throughout all phases of a clinical trial in order to achieve success.
Sign up to download FDA Inspection Trends
Our records indicate your email already exists. Please login above.
When you register to become a member, you gain access to white papers and the ability to reach out to companies directly. As part of your membership, we’ll keep you up-to-date on current news, research and analysis with our Business Chatter Weekly e-Newsletter.